Search

This document aims to collate and present the lessons identified from the public health stakeholders who responded to the COVID-19 pandemic. It is intended to serve as input for countries revising their pandemic or emergency preparedness plans.

The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period 23-29 April 2023 and includes updates on cholera, avian influenza, COVID-19, invasive meningococcal disease, influenza, Marburg virus disease, and the seizure of a reference laboratory by an armed group.

The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 16-22 April 2023 and includes updates on influenza, avian influenza, Marburg virus disease, COVID-19 and poliomyelitis.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 9-15 April 2023 and includes updates on influenza, Marburg virus disease, COVID-19, MERS-CoV, Measles and diphtheria.

This document offers an overview of the available scientific evidence and epidemiological situation and provides public health considerations to support discussions and decisions on the planning and implementation of COVID-19 vaccination campaigns for 2023.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 26 March - 1 April 2023 and includes updates on Iatrogenic botulism exposure in Türkiye, COVID-19, group A streptococcal infection, influenza, swine influenza. Marburg virus disease and poliomyelitis.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19-25 March 2023 and includes updates on Marburg virus disease, iatrogenic botulism, COVID-19, Influenza, Group A streptococcal infection, cholera, poliomyelitis, measles, and extensively drug-resistant Pseudomonas aeruginosa.

This document aims to support countries in designing after-action reviews (AARs) of the public health response to COVID-19. It has been designed to draw upon pre-existing ECDC guidance and follows a methodological approach combining interactive workshops and interviews. The Annexes feature practical implementation tools.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 12-18 March 2023 and includes updates on COVID-19, iatrogenic botulism, group A streptococcal infection, influenza, chikungunya and dengue, and influenza B among young people.

This update reports on one of the ECDC multi-country studies that is centred around the hospital setting and severe disease, with the aim of assessing vaccine effectiveness against severe acuterespiratory infection (SARI) due to laboratory-confirmed SARS-CoV-2 within the ECDC VaccineEffectiveness, Burden and Impact Studies infrastructure (VEBIS) [1,2].